Xvivo Perfusion AB (publ) (XVIVO.ST) Financials
XVIVO.ST Assets vs Liabilities
| Date | Assets | Liabilities |
|---|---|---|
| March 31, 2026 | 2.5 billion | 299.6 million |
| Dec. 31, 2025 | 2.4 billion | 260.7 million |
| Sept. 30, 2025 | 2.4 billion | 283.5 million |
| June 30, 2025 | 2.4 billion | 295.5 million |
XVIVO.ST Free Cash Flow and Stock based compensation
Graph available only for paid members. Upgrade to see it.
| Date | Free Cash Flow | Stock based compensation |
|---|---|---|
| March 31, 2026 | 65.3 million | ? |
| Dec. 31, 2025 | 86.9 million | ? |
| Sept. 30, 2025 | ? | ? |
| June 30, 2025 | 8.8 million | ? |
XVIVO.ST Net Income
Graph available only for paid members. Upgrade to see it.
| Date | Net Income |
|---|---|
| March 31, 2026 | 42.8 million |
| Dec. 31, 2025 | 31.6 million |
| Sept. 30, 2025 | 4.3 million |
| June 30, 2025 | -3.3 million |
XVIVO.ST Cash and Debt
Graph available only for paid members. Upgrade to see it.
| Date | Cash | Debt | Capital Lease |
|---|---|---|---|
| March 31, 2026 | 308.1 million | - | 111.3 million |
| Dec. 31, 2025 | 292.1 million | 113.2 million | 113.2 million |
| Sept. 30, 2025 | 279.9 million | 114.6 million | 114.6 million |
| June 30, 2025 | 323.0 million | 103.0 million | 103.0 million |
XVIVO.ST Shares Outstanding
XVIVO.ST Expenses
Graph available only for paid members. Upgrade to see it.
| Date | Capex | R&D | G&A | S&M |
|---|---|---|---|---|
| March 31, 2026 | - | 36.8 million | 102.9 million | 73.6 million |
| Dec. 31, 2025 | 86.9 million | 25.2 million | 93.8 million | 74.9 million |
| Sept. 30, 2025 | 20.6 million | 23.9 million | 83.7 million | - |
| June 30, 2025 | - | 31.9 million | 94.2 million | 75.8 million |
XVIVO.ST Cost of Revenue
Graph available only for paid members. Upgrade to see it.
| Date | Revenue | Cost of Revenue |
|---|---|---|
| March 31, 2026 | 241.0 million | 69.9 million |
| Dec. 31, 2025 | 226.1 million | 111.6 million |
| Sept. 30, 2025 | 189.1 million | 63.2 million |
| June 30, 2025 | 178.3 million | 45.6 million |
XVIVO.ST
Price: SEK277.60
52 week price:
Earnings Per Share: 2.33 SEK
P/E Ratio: 117.77
Exchange: STO
Sector: Healthcare
Industry: Medical Devices
Market Capitalization: 8.6 billion